Patent details
EP2984097
Title:
HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV
Basic Information
- Publication number:
- EP2984097
- PCT Application Number:
- US2014034018
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP147229553
- PCT Publication Number:
- WO2014169278
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV
- French Title of Invention:
- DÉRIVÉ DE NUCLÉOSIDE D'ACTIVITÉ ÉLEVÉE POUR LE TRAITEMENT DU VHC
- German Title of Invention:
- HOCHAKTIVE NUKLEOSIDDERIVATE ZUR BEHANDLUNG VON HCV
- SPC Number:
-
Dates
- Filing date:
- 14/04/2014
- Grant date:
- 29/03/2017
- EP Publication Date:
- 17/02/2016
- PCT Publication Date:
- 16/10/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/03/2017
- EP B1 Publication Date:
- 29/03/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/04/2017
- Expiration date:
- 14/04/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/03/2017
-
-
- Name:
- Achillion Pharmaceuticals, Inc.
- Address:
- 300 George Street, New Haven, CT 06511, United States (US)
Inventor
1
- Name:
- PHADKE, Avinash
- Address:
- United States (US)
2
- Name:
- DESHPANDE, Milind
- Address:
- United States (US)
3
- Name:
- HASHIMOTO, Akihiro
- Address:
- United States (US)
4
- Name:
- WILES, Jason Allan
- Address:
- United States (US)
Priority
- Priority Number:
- 201361811464 P
- Priority Date:
- 12/04/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/7072;
A61P 31/14;
C07B 59/00;
C07H 19/067;
Publication
European Patent Bulletin
- Issue number:
- 201713
- Publication date:
- 29/03/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-